Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients with Inflammatory or Invasive Breast Cancer
Recruiting in Palo Alto (17 mi)
+9 other locations
VV
Overseen byVIcente Valero, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: M.D. Anderson Cancer Center
No Placebo Group
Trial Summary
What is the purpose of this trial?
This trial studies the biospecimen and medical data collection in creating a research tissue registry in patients with inflammatory or invasive breast cancer. Collecting medical data and storing samples of blood, tissue, and stool from patients with inflammatory breast cancer to study in the laboratory may help doctors find better ways to treat and study inflammatory breast cancer in the future.
Research Team
VV
VIcente Valero, MD
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
Inclusion Criteria
Age > 18 years
Patients with clinical diagnosis of primary inflammatory breast cancer (IBC), second primary IBC, or highly suspicious for IBC (MD Anderson patients only).
Histological diagnosis of invasive breast cancer, or highly suspicious for IBC (MD Anderson patients only) but pending breast cancer diagnosis.
See 2 more
Treatment Details
Interventions
- Biospecimen Collection (N/A)
- Interview (N/A)
- Medical Chart Review (N/A)
- Questionnaire Administration (N/A)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Observational (biospecimen and medical data collection)Experimental Treatment4 Interventions
Patients complete questionnaires and participate in interview over 30 minutes. Patients also undergo collection of medical data and blood, tissue, and stool samples.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Baptist - MD Anderson Cancer CenterJacksonville, FL
Banner - MD Anderson Cancer Center - Northern ColoradoGreeley, CO
Banner - MD Anderson Cancer CenterGilbert, AZ
MD Anderson in KatyHouston, TX
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Trials
3107
Patients Recruited
1,813,000+
National Cancer Institute (NCI)
Collaborator
Trials
14080
Patients Recruited
41,180,000+
Texas Appropriation for Rare and Aggressive diseases
Collaborator
Trials
1
Patients Recruited
1,200+